28 related articles for article (PubMed ID: 10606306)
1. Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals.
Segal R; Russell WL; Oh T; Ben-Joseph R
Am J Hosp Pharm; 1993 Oct; 50(10):2077-81. PubMed ID: 8238052
[TBL] [Abstract][Full Text] [Related]
2. Ranitidine as adjuvant treatment in colorectal cancer.
Nielsen HJ; Christensen IJ; Moesgaard F; Kehlet H;
Br J Surg; 2002 Nov; 89(11):1416-22. PubMed ID: 12390384
[TBL] [Abstract][Full Text] [Related]
3. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
[TBL] [Abstract][Full Text] [Related]
4. Adjusting dosage intervals of intermittent intravenous ranitidine according to creatinine clearance: a cost-minimization analysis.
Connelly JF
Hosp Pharm; 1994 Nov; 29(11):992, 996-8, 1001. PubMed ID: 10138581
[TBL] [Abstract][Full Text] [Related]
5. The use of intravenous H2-receptor antagonists in a tertiary care hospital.
Dettmer RM; Riley TH; Byfield F; Green PH
Am J Gastroenterol; 1999 Dec; 94(12):3473-7. PubMed ID: 10606306
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity reaction to ranitidine: description of a case and review of the literature.
Foti C; Cassano N; Panebianco R; Calogiuri GF; Vena GA
Immunopharmacol Immunotoxicol; 2009; 31(3):414-6. PubMed ID: 19694603
[TBL] [Abstract][Full Text] [Related]
7. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
Geus WP
Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
[TBL] [Abstract][Full Text] [Related]
8. Antiulcer therapy: an exercise in formulary management.
Foulke GE; Siepler J
J Clin Gastroenterol; 1990; 12 Suppl 2():S64-8. PubMed ID: 1978846
[TBL] [Abstract][Full Text] [Related]
9. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.
Khuroo MS; Khuroo MS; Farahat KL; Kagevi IE
J Gastroenterol Hepatol; 2005 Jan; 20(1):11-25. PubMed ID: 15610441
[TBL] [Abstract][Full Text] [Related]
10. Possible cholestatic injury from ranitidine with a review of the literature.
Ramrakhiani S; Brunt EM; Bacon BR
Am J Gastroenterol; 1998 May; 93(5):822-6. PubMed ID: 9625136
[TBL] [Abstract][Full Text] [Related]
11. How often we diagnose allergy to ranitidine?
Bocșan IC; Sabin O; Matei D; Muntean A; Buzoianu AD
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10812-10818. PubMed ID: 33155242
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
